Background Patient specimens can be subject to subtle interference from cross contamination by liquid-based, potassium-containing EDTA anticoagulant, leading to misinterpretation of results. A rapid method for EDTA analysis to detect such contamination is described.
Introduction
Contamination during collection of blood specimens by droplet transfer of liquid potassium EDTA-containing anticoagulants or preservatives, via a syringe tip, can lead to production of erroneous, yet credible, laboratory data. 1, 2 To avoid misinterpretation of biochemical ¢ndings, a rapid technique to detect low-level EDTA contamination is required. 2 In an ethanol acetate bu¡er (pH 4.8) EDTA abstracts copper ions from a violet-coloured pyridylazonaphtholcopper (PAN-Cu) complex to yield yellow-coloured free PAN. The decrease in solution absorbance as the complex is de-coppered by EDTA is proportional, in a non-linear fashion, to the EDTA concentration in the sample. 3, 4 
Methods
Measurements of EDTA and other analytes, including calcium by o-cresolphthalein complexone (OCPC) colorimetry, were performed on a Roche/Hitachi MODU-LAR s analytical system (Roche Diagnostics GmbH, Mannheim, Germany). Additional calcium analyses were performed by atomic absorption spectrophotometry (AAS) on a Hitachi model Z8200 according to the manufacturer's speci¢cation (Hitachi Ltd, Tokyo, Japan). Patients' blood specimens were collected using the Sarstedt Monovette R system (Sarstedt Ltd, Leicester, UK), which uses liquid tri-potassium EDTA as anticoagulant in full blood count testing and liquid sodium EDTA in combination with potassium £uoride as specimen anticoagulant/preservative for glucose analysis. Analyses were performed on either serum or lithium heparin plasma.
Colour reagent contained PAN-Cu (60 mmol/L), ethanol (30% v/v), Triton X-100 (1% v/v) and acetate bu¡er (200 mmol/L, pH 4.8). In the automated colorimetric EDTA assay, serum or plasma (20 mL) was sampled, followed by addition of 224 mL of colour reagent. The decrease in absorbance was monitored using bichromatic spectrophotometry at primary and secondary wavelengths of 546 and 660 nm respectively. A sixpoint calibration was prepared from lyophilized human serum in the range 0--0.5 mmol/L and this was performed with each batch of colour reagent using a logit-log mathematical model (logit-log 4P).
Calcium is una¡ected by the presence of EDTA when measured by AAS. 5 The relationship between the two quantities Ca (AAS) and Ca (OCPC) was determined by analysis of 101 EDTA-free patients' plasma samples by each of the calcium methods to produce a slope (S) and intercept (I) by Deming's regression. The accuracy of the colorimetric EDTA assay was determined by comparison via the adjusted equation EDTA ¼ [((Ca (AAS) --I)/S) --Ca (OCPC) ] mmol/L, using samples obtained from 94 patients whose plasma was considered to be contaminated with EDTA during blood collection and exhibited measurable (i.e. non-zero) calcium values.
Inter-assay precision of the colorimetric EDTA assay was assessed by replicate (n ¼ 32) measurement of the human-based quality control serum adjusted to a nominal EDTA concentration of 0.25 mmol/L. The precision of the calcium di¡erence comparison method was estimated indirectly from replicate (n ¼ 32) measurement of calcium on the same quality control serum, by both the AAS and OCPC techniques, each at a nominal calcium concentration of 2.0 mmol/L.
The limit of detection of the colorimetric EDTA assay was assessed by analysis of 40 visibly unhaemolysed, EDTA-free, non-lipaemic lithium heparin plasma samples and calculated as mean þ 3 SD.
A haemolysate prepared by deep freezing (À201C) red cells of EDTA-free blood followed by dilution in zero calibrator serum was used to produce a range of haemoglobin concentrations (zero to 20 g/L). The e¡ect of lipaemia was assessed up to a triglyceride concentration of 26 mmol/L, of icterus up to a bilirubin concentration of 530 mmol/L, of glucose up to 100 mmol/L, of iron up to 118 mmol/L, and each of citrate, phosphate, oxalate and £uoride up to sample concentrations of 2.5 mmol/L.
Results

Accuracy
Regression of Ca (AAS) versus Ca (OCPC) for the 101 EDTAfree plasma samples yielded a slope (S) of 0.946 (95% con¢dence interval [CI] 0.916--0.977) and intercept (I) of 0.107 (95% CI 0.034--0.179) mmol/L, thereby yielding an adjusted equation of the form: EDTA ¼ [((Ca (AAS) --0.107)/0.946) --Ca (OCPC) ] mmol/L. For the 94 patients whose samples were deemed to have been contaminated with liquid-based EDTA anticoagulant during blood collection, regression (Passing and Bablok) of the results of the automated EDTA assay with those by the adjusted calcium di¡erence equation yielded a slope of 1.038 (95% CI 0.949--1.131) and an intercept of 0.073 (95% CI 0.018--0.132) mmol/L; r ¼ 0.914 (Figure 1 ). EDTA conc (mmol/L) adjusted calcium difference method EDTA conc (mmol/L) automated colorimetric method Figure 1 Relationship between EDTA concentration by the automated colorimetric method and that by the adjusted calcium difference method for 94 patient samples (the line shown is the line of equivalence) Ann Clin Biochem 2007; 44: 294-296 Sensitivity Forty EDTA-free samples showed a mean (range) EDTA concentration by the automated colorimetric assay of 0.05. (0.02--0.10) and SD of 0.019 mmol/L, giving a limit of detection of 0.11mmol/L. For application in routine practice, this ¢gure was rounded up to provide a ¢gure for unequivocal EDTA contamination of X0.2 mmol/L.
Precision
Specificity
The method was subject to positive interference from haemolysis, e.g. haemoglobin concentrations of 6.6 and 12 g/L produced EDTA concentrations of 0.30 and 0.42 mmol/L, respectively, in EDTA-free serum. The method was una¡ected by the presence of lipaemia (tri-glycerideso20 mmol/L), icterus (bilirubino500 mmol/L), glucose (o100 mmol/L), iron (o100 mmol/L), citrate (o2.5 mmol/L), phosphate (o2.5 mmol/L) or £uoride (o2.5 mmol/L). The presence of oxalate in the sample resulted in negative interference. For example, in 0.4 mmol/L EDTA calibrator serum, oxalate concentrations of 1.0 and 2.0 mmol/L produced EDTA concentrations of 0.26 and 0.15 mmol/L respectively. However, oxalate is not used as a specimen anticoagulant in this laboratory.
Discussion
The method was developed in response to a perceived increase in the number of cases of erroneous hyperkalaemia following introduction of the Monovette R blood collection system. 2 In this laboratory, the current workload includes 400,000 potassium analyses per year. As a relatively arbitrary cut-o¡, unhaemolysed specimens with potassium 45.5 mmol/L are automatically analysed for the presence of EDTA. Approximately 5000 EDTA analyses are performed annually of which 4400 per year exhibit an EDTA concentration X0.2 mmol/L. Two-thirds of these lie in the range 0.2--1.0 mmol/L (median 0.55 mmol/L). Additional discretionary EDTA analysis may be performed in response to hypocalcaemia, hypomagnesaemia, hypophosphatasaemia or high unsaturated iron-binding capacity. 2 On encountering samples that are positive for EDTA, results for potassium, calcium, magnesium, alkaline phosphatase and iron-binding capacity are suppressed, and a request is made to obtain a repeat specimen. Despite continuing education, the number of EDTA-contaminated specimens detected has continued to increase annually in line with increase in overall workload. The automated colorimetric method is rapid and takes only 3 min between sampling and reporting of the EDTA result.
